SUPN
Supernus Pharmaceuticals Inc
42.10$
-2.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 0.0% | -22.6% | -12,645.3% | 4,691.9% | 2,890.4% | 9.2% | 4.7% | 5.8% | 5.6% | 5.0% | 3.8% | 4.2% | 10.1% | 12.9% | 13.1% | 13.8% | 11.8% | 10.4% | |
| 100.0% | 100.0% | 122.6% | 12,745.3% | 100.0% | 100.0% | 90.8% | 95.3% | 94.2% | 94.4% | 95.0% | 96.2% | 95.8% | 89.9% | 87.1% | 86.9% | 86.2% | 88.2% | 89.6% | |
| 455.2% | 342.7% | 77.2% | 33,159.4% | 3,814.1% | 1,589.0% | 143.5% | 16.0% | 20.2% | 19.9% | 16.4% | 21.8% | 17.6% | 14.6% | 15.6% | 11.2% | 15.1% | 16.4% | 14.8% | |
| – | 48.2% | 12.3% | 4,792.5% | – | 968.4% | 341.0% | 47.3% | 48.4% | 39.1% | 34.4% | 28.5% | 29.9% | 12.7% | 18.1% | 16.4% | 39.0% | 37.4% | 27.4% | |
| 549.9% | 390.9% | 89.4% | 37,951.9% | 4,801.4% | 2,949.3% | 606.0% | 75.4% | 81.9% | 69.2% | 62.0% | 60.9% | 57.9% | 56.5% | 72.2% | 80.0% | 87.1% | 75.9% | 94.8% | |
| -449.9% | -290.9% | 10.6% | -37,851.9% | -4,701.4% | -2,849.3% | -515.2% | 19.9% | 12.2% | 25.2% | 32.9% | 35.3% | 37.8% | 33.4% | 14.8% | 6.9% | -0.9% | 12.3% | -5.1% | |
| 41.9% | 97.6% | 0.3% | 100.9% | 232.4% | 241.6% | 65.3% | 4.6% | 3.3% | 2.4% | 0.5% | 4.4% | 5.8% | 4.6% | 4.0% | 1.1% | 0.4% | 0.0% | 0.0% | |
| -408.0% | -376.7% | 10.9% | -37,239.6% | -4,915.3% | -3,127.3% | -767.7% | 16.3% | 10.4% | 23.4% | 33.3% | 34.3% | 37.6% | 32.4% | 12.6% | 9.1% | 0.5% | 14.8% | -6.8% | |
| 41.9% | 11.9% | 10.0% | -376.4% | -2,023.0% | 77.2% | 59.1% | 3.3% | 0.7% | -19.0% | 14.3% | 7.1% | 8.8% | 8.0% | 3.4% | 0.0% | 0.2% | 3.6% | -1.5% | |
| -408.0% | -376.7% | 1.2% | -36,285.8% | 6,974.2% | -3,127.3% | -767.7% | 16.3% | 9.7% | 42.4% | 19.0% | 27.1% | 28.8% | 24.4% | 9.2% | 9.1% | 0.2% | 11.2% | -5.4% | |
| -386.0% | -266.5% | 13.7% | -36,118.9% | -4,573.5% | -2,826.9% | -696.2% | -3.6% | 15.1% | 26.3% | 35.6% | 37.1% | 45.9% | 40.5% | 22.3% | 23.0% | 14.8% | 26.9% | 5.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.